BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38686454)

  • 21. Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2.
    Lima Neto JX; Bezerra KS; Barbosa ED; Araujo RL; Galvão DS; Lyra ML; Oliveira JIN; Akash S; Jardan YAB; Nafidi HA; Bourhia M; Fulco UL
    Front Mol Biosci; 2023; 10():1325588. PubMed ID: 38304231
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.
    Yan L; Ge J; Zheng L; Zhang Y; Gao Y; Wang T; Huang Y; Yang Y; Gao S; Li M; Liu Z; Wang H; Li Y; Chen Y; Guddat LW; Wang Q; Rao Z; Lou Z
    Cell; 2021 Jan; 184(1):184-193.e10. PubMed ID: 33232691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
    Padhi AK; Tripathi T
    Biochem Biophys Res Commun; 2021 May; 555():147-153. PubMed ID: 33813274
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Tonelli M; Rienstra C; Anderson TK; Kirchdoerfer R; Henzler-Wildman K
    Biomol NMR Assign; 2021 Apr; 15(1):73-77. PubMed ID: 33219414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
    Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
    Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
    Dhankhar P; Dalal V; Kumar V
    J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    Freidel MR; Armen RS
    PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonstructural proteins 7 and 8 of feline coronavirus form a 2:1 heterotrimer that exhibits primer-independent RNA polymerase activity.
    Xiao Y; Ma Q; Restle T; Shang W; Svergun DI; Ponnusamy R; Sczakiel G; Hilgenfeld R
    J Virol; 2012 Apr; 86(8):4444-54. PubMed ID: 22318142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility.
    Kim SM; Kim EH; Casel MAB; Kim YI; Sun R; Kwak MJ; Yoo JS; Yu M; Yu KM; Jang SG; Rollon R; Choi JH; Gil J; Eun K; Kim H; Ensser A; Hwang J; Song MS; Kim MH; Jung JU; Choi YK
    Cell Rep; 2023 Sep; 42(9):113077. PubMed ID: 37676771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.
    Long SW; Olsen RJ; Christensen PA; Bernard DW; Davis JJ; Shukla M; Nguyen M; Saavedra MO; Yerramilli P; Pruitt L; Subedi S; Kuo HC; Hendrickson H; Eskandari G; Nguyen HAT; Long JH; Kumaraswami M; Goike J; Boutz D; Gollihar J; McLellan JS; Chou CW; Javanmardi K; Finkelstein IJ; Musser JM
    mBio; 2020 Oct; 11(6):. PubMed ID: 33127862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding properties of selective inhibitors of P323L mutated RdRp of SARS-CoV-2: a combined molecular screening, docking and dynamics simulation study.
    Chinnamadhu A; Ramakrishnan J; Suresh S; Poomani K
    J Biomol Struct Dyn; 2024 May; 42(8):4283-4296. PubMed ID: 37301607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.
    Baddock HT; Brolih S; Yosaatmadja Y; Ratnaweera M; Bielinski M; Swift LP; Cruz-Migoni A; Fan H; Keown JR; Walker AP; Morris GM; Grimes JM; Fodor E; Schofield CJ; Gileadi O; McHugh PJ
    Nucleic Acids Res; 2022 Feb; 50(3):1484-1500. PubMed ID: 35037045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
    Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
    Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hallmarks of
    Krichel B; Bylapudi G; Schmidt C; Blanchet C; Schubert R; Brings L; Koehler M; Zenobi R; Svergun D; Lorenzen K; Madhugiri R; Ziebuhr J; Uetrecht C
    Sci Adv; 2021 Mar; 7(10):. PubMed ID: 33658206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro.
    Miropolskaya N; Kozlov M; Petushkov I; Prostova M; Pupov D; Esyunina D; Kochetkov S; Kulbachinskiy A
    Biochimie; 2023 Mar; 206():81-88. PubMed ID: 36252889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes.
    Zekri AN; Mohanad M; Hafez MM; Soliman HK; Hassan ZK; Abouelhoda M; Amer KE; Seadawy MG; Ahmed OS
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166154. PubMed ID: 33932525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging genetic diversity of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) alters its B-cell epitopes.
    Kumar S; Kumari K; Azad GK
    Biologicals; 2022 Jan; 75():29-36. PubMed ID: 34802866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.